Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ludmil B Alexandrov
Affiliation
Moores Cancer Center, university of california san diego
ORCID
Career Start Year
2007
Papers
146
H Index
63
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37971722
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
JAMA Oncol
2024
37971722
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
JAMA Oncol
2024
36928603
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Nat Genet
2023
37605126
Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator.
BMC Genomics
2023
37735199
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
Nat Genet
2023
38096571
Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
Bioinformatics
2023
36778452
Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator.
bioRxiv
2023
36650165
DNA damage and somatic mutations in mammalian cells after irradiation with a nail polish dryer.
Nat Commun
2023
36756361
Unraveling the impact of a germline heterozygous <i>POLD1</i> frameshift variant in serrated polyposis syndrome.
Front Mol Biosci
2023
36702933
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nat Cancer
2023
36697836
Author Correction: The repertoire of mutational signatures in human cancer.
Nature
2023
37316668
Mitotic tethering enables inheritance of shattered micronuclear chromosomes.
Nature
2023
36865271
Arsenic is a potent co-mutagen of ultraviolet light.
bioRxiv
2023
37173324
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Nat Commun
2023
37046091
Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats.
Nature
2023
37046089
Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus.
Nature
2023
36928603
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Nat Genet
2023
36604421
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis.
Nat Commun
2023
36918603
Author Correction: DNA damage and somatic mutations in mammalian cells after irradiation with a nail polish dryer.
Nat Commun
2023
37540596
Topography of mutational signatures in human cancer.
Cell Rep
2023
37502962
Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
bioRxiv
2023
36525930
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
Gynecol Oncol
2023
37502962
Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
bioRxiv
2023
37735199
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
Nat Genet
2023
37540596
Topography of mutational signatures in human cancer.
Cell Rep
2023
38096571
Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
Bioinformatics
2023
37605126
Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator.
BMC Genomics
2023
37316668
Mitotic tethering enables inheritance of shattered micronuclear chromosomes.
Nature
2023
37046091
Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats.
Nature
2023
37046089
Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus.
Nature
2023
37173324
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Nat Commun
2023
36697836
Author Correction: The repertoire of mutational signatures in human cancer.
Nature
2023
36650165
DNA damage and somatic mutations in mammalian cells after irradiation with a nail polish dryer.
Nat Commun
2023
36918603
Author Correction: DNA damage and somatic mutations in mammalian cells after irradiation with a nail polish dryer.
Nat Commun
2023
36778452
Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator.
bioRxiv
2023
36604421
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis.
Nat Commun
2023
36865271
Arsenic is a potent co-mutagen of ultraviolet light.
bioRxiv
2023
36702933
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nat Cancer
2023
36756361
Unraveling the impact of a germline heterozygous <i>POLD1</i> frameshift variant in serrated polyposis syndrome.
Front Mol Biosci
2023
36525930
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
Gynecol Oncol
2023
35140368
Unwinding the mutational signatures of a DNA topoisomerase enzyme.
Nature
2022
35595234
Examining clustered somatic mutations with SigProfilerClusters.
Bioinformatics
2022
36042521
A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Genome Med
2022
35705804
Signatures of copy number alterations in human cancer.
Nature
2022
35641325
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
Gynecol Oncol
2022
35420163
An overview of mutational and copy number signatures in human cancer.
J Pathol
2022
36134663
AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas.
JCI Insight
2022
35859169
Mechanisms of APOBEC3 mutagenesis in human cancer cells.
Nature
2022
36395141
Somatic 9p24.1 alterations in HPV<sup>-</sup> head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity.
Proc Natl Acad Sci U S A
2022
36388765
Uncovering novel mutational signatures by <i>de novo</i> extraction with SigProfilerExtractor.
Cell Genom
2022
1 - 50 of 292
Column Actions
Search
Recommended Authors
Ander Diaz-Navarro
Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo
Career Start Year
2018
Number of shared co-authors
11
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year
2015
Number of shared co-authors
8
Julian M Hess
Broad Institute of MIT and Harvard
Career Start Year
2015
Number of shared co-authors
15
Daniele Ramazzotti
University of Milano-Bicocca
Career Start Year
2015
Number of shared co-authors
0
Shantao Li
Yale University
Career Start Year
2015
Number of shared co-authors
4
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year
2014
Number of shared co-authors
45
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2011
Number of shared co-authors
27
Francesco Favero
Universita del Piemonte Orientale
Career Start Year
2010
Number of shared co-authors
17
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year
2009
Number of shared co-authors
9
Joshua F McMichael
Washington University
Career Start Year
2009
Number of shared co-authors
12
Lixing Yang
University of Chicago, USA University of Chicago Comprehensive Cancer Center
Career Start Year
2008
Number of shared co-authors
12
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
7
Cyriac Kandoth
University of California los angeles
Career Start Year
2008
Number of shared co-authors
57
Giovanni Ciriello
University of Lausanne (UNIL)
Career Start Year
2008
Number of shared co-authors
11
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
23
Sigve Nakken
University of Oslo
Career Start Year
2007
Number of shared co-authors
44
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year
2006
Number of shared co-authors
19
Paz Polak
McGill University
Career Start Year
2006
Number of shared co-authors
20
Jeroen de Ridder
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year
2006
Number of shared co-authors
32
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
17
Christina Curtis
Stanford University School of Medicine
Career Start Year
2004
Number of shared co-authors
17
Joachim Weischenfeldt
University of Copenhagen
Career Start Year
2004
Number of shared co-authors
53
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
39
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
67
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year
2003
Number of shared co-authors
19
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year
1999
Number of shared co-authors
15
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year
1998
Number of shared co-authors
31
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
63
Fran Supek
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year
1992
Number of shared co-authors
1
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
57
row(s) 1 - 30 of 30
Collaborators
Michael R Stratton
Wellcome Sanger Institute
Co-authored papers
43
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers
39
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers
32
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers
24
Inigo Martincorena
Wellcome Sanger Institute
Co-authored papers
21
Peter Van Loo
The Francis Crick Institute
Co-authored papers
20
Adam Butler
Wellcome Sanger Institute
Co-authored papers
18
Keiran Raine
Wellcome Sanger Institute
Co-authored papers
16
Jon Teague
Wellcome Sanger Institute
Co-authored papers
15
Manasa Ramakrishna
Co-authored papers
14
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers
14
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers
12
Andrew Menzies
Wellcome Sanger Institute
Co-authored papers
12
Andrea L Richardson
Co-authored papers
12
David Jones
Wellcome Sanger Institute
Co-authored papers
12
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers
11
Patrick S Tarpey
Wellcome Trust Sanger Institute
Co-authored papers
11
Laura Mudie
Wellcome Trust Sanger Institute
Co-authored papers
10
Moritz Gerstung
German Cancer Research Centre DKFZ
Co-authored papers
10
Stuart McLaren
Wellcome Trust Sanger Institute
Co-authored papers
10
Sarah O'Meara
Clinical Research Facility, Mercy University Hospital
Co-authored papers
9
Lucy A Stebbings
Wellcome Trust Sanger Institute
Co-authored papers
9
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers
9
Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
Co-authored papers
9
Mark Maddison
Wellcome Sanger Institute
Co-authored papers
8
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers
8
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers
8
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers
8
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers
7
Jonathan Hinton
Inivata Ltd
Co-authored papers
7
1 - 30